Immatics Common Stock Shares Outstanding from 2010 to 2025

IMTXW Stock  USD 0.03  0.0005  1.62%   
Immatics Biotechnologies Common Stock Shares Outstanding yearly trend continues to be fairly stable with very little volatility. Common Stock Shares Outstanding will likely drop to about 70.8 M in 2025. Common Stock Shares Outstanding is the total number of shares of a company's common stock that are currently owned by all its shareholders. View All Fundamentals
 
Common Stock Shares Outstanding  
First Reported
2018-03-31
Previous Quarter
106 M
Current Value
103.1 M
Quarterly Volatility
13.3 M
 
Covid
Check Immatics Biotechnologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Immatics Biotechnologies' main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 15.7 M or Interest Income of 16.7 M, as well as many indicators such as Price To Sales Ratio of 15.53, Dividend Yield of 0.0 or PTB Ratio of 3.22. Immatics financial statements analysis is a perfect complement when working with Immatics Biotechnologies Valuation or Volatility modules.
  
Check out the analysis of Immatics Biotechnologies Correlation against competitors.

Latest Immatics Biotechnologies' Common Stock Shares Outstanding Growth Pattern

Below is the plot of the Common Stock Shares Outstanding of immatics biotechnologies GmbH over the last few years. It is the total number of shares of a company's common stock that are currently owned by all its shareholders. Immatics Biotechnologies' Common Stock Shares Outstanding historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Immatics Biotechnologies' overall financial position and show how it may be relating to other accounts over time.
Common Stock Shares Outstanding10 Years Trend
Slightly volatile
   Common Stock Shares Outstanding   
       Timeline  

Immatics Common Stock Shares Outstanding Regression Statistics

Arithmetic Mean65,799,134
Geometric Mean65,196,391
Coefficient Of Variation14.58
Mean Deviation6,198,660
Median62,908,617
Standard Deviation9,591,597
Sample Variance92T
Range44.6M
R-Value0.49
Mean Square Error74.5T
R-Squared0.24
Significance0.05
Slope995,990
Total Sum of Squares1380T

Immatics Common Stock Shares Outstanding History

202570.8 M
202492.6 M
202380.5 M
202268.8 M
202162.9 M
202048 M

About Immatics Biotechnologies Financial Statements

Immatics Biotechnologies investors use historical fundamental indicators, such as Immatics Biotechnologies' Common Stock Shares Outstanding, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Immatics Biotechnologies. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Common Stock Shares Outstanding92.6 M70.8 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Immatics Stock Analysis

When running Immatics Biotechnologies' price analysis, check to measure Immatics Biotechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immatics Biotechnologies is operating at the current time. Most of Immatics Biotechnologies' value examination focuses on studying past and present price action to predict the probability of Immatics Biotechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immatics Biotechnologies' price. Additionally, you may evaluate how the addition of Immatics Biotechnologies to your portfolios can decrease your overall portfolio volatility.